Τόμος 13 (1995) – Τεύχος 1 – Άρθρο 1 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση – Volume 13 (1995) – Issue 1 – Article 1 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

 

Τίτλος – Title

Ο πιθανός ρόλος της σταθερότητας του RNA του Messenger (mRNA) στο γονίδιο. Έκφραση και ανάπτυξη νέων Θεραπευτικών

Potential Role of Messenger RNA (mRNA) Stability in Gene. Ex­pression and Development of new Therapeutics

Συγγραφέας – Author

Ιωάννης Βιζιριανάκης και Αστέριος Σ. Τσιφτσόγλου

Eργαστήριο Φαρμακολογίας, Τμήμα Φαρμακολογίας-Φαρμακογνωσίας, Τμήμα Φαρμακευτικής, Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης, 540 06 Θεσσαλονίκη

Ioannis Vizirianakis and Asterios S. Tsiftsoglou

Laboratory of Pharmacology, Division of Pharma­cognosy-Pharmacology, Department of Pharma­ceutical Sciences, Aristotle University of Thessa­loniki, 540 06 Thessaloniki, Greece

Παραπομπή – Citation

Βιζιριανάκης,Ι., Τσιφτσόγλου,Α.Σ. : O Püëoò της Σταθερότητας των Moñßùí τoυ Aããåëéáöüñïõ RNA (mRNA) στον Έλεγxo της Γενετικής Έκφρασης στα Eõêáñõùôéêá Kýôôáñá και στην AíÜðôõîç Θεραπευτικών Oõóéþí , Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 14 : 7-32 (1996)

Vizirianakis,I., Tsiftsoglou,A.S. : Potential Role of Messenger RNA (mRNA) Stability in Gene. Ex­pression and Development of new Therapeutics, Epitheorese Klin. Farmakol. Farmakokinet. 14 : 7-32 (1996)

Ημερομηνία Δημοσιευσης – Publication Date
15-02-1995
Γλώσσα Πλήρους Κειμένου –
Full Text Language

Ελληνικά – Greek

Παραγγελία – Αγορά –
Order – Buy
Ηλεκτρονική Μορφή: pdf (15 €)
Digital Type: pdf (15 )
pharmakonpress[at]pharmakonpress[.]gr
Λέξεις κλειδιά – Keywords

Σταθερότητα mRNA, έκφραση γονιδίων, ευκαρυωτικά κύτταρα

mRNA stability, gene expression, eukaryotic cells
Λοιποί Όροι – Other Terms

Άρθρο

Article

Περίληψη – Summary

Eðåé­äÞ σε πολ­λά α­να­πτυ­ξια­κά συ­στή­μα­τα ζω­ϊ­κών κυτ­τά­ρων η δια­θέ­σι­μη προς με­τά­φρα­ση πο­σό­τη­τα του mRNA πολ­λών πρω­τε­ϊ­νών με­τα­βάλ­λε­ται, υ­πάρ­χει έ­ντο­νο εν­δια­φέ­ρον για τον τρό­πο με τον ο­ποί­ο ρυθ­μί­ζε­ται αυ­τή η πο­σό­τη­τα του mRNA (steady-state level). Ση­μα­ντι­κό ρό­λο στη δια­δι­κα­σί­α αυ­τή φαί­νε­ται να δια­δρα­μα­τί­ζουν τό­σο ο ρυθ­μός πα­ρα­γω­γής του mRNA κα­τά τη με­τα­γρα­φή του DNA, ό­σο και η τα­χύ­τη­τα ω­ρί­μαν­σης (RNA splicing) και η στα­θε­ρό­τη­τα (stability) του ι­δί­ου του mRNA, δη­λα­δή ο ρυθ­μός διά­σπα­σής του. Tá τε­λευ­ταί­α χρό­νια, σε ο­ρι­σμέ­νες του­λά­χι­στον πε­ρι­πτώ­σεις, διε­πι­στώ­θη ό­τι τα mRNAs δια­θέ­τουν πρω­το­τα­γείς και δευ­τε­ρο­τα­γείς δο­μές και δια­μορ­φώ­σεις, που δια­δρα­μα­τί­ζουν ση­μα­ντι­κό ρό­λο στη διά­σπα­ση τους, για­τί τους ε­πι­τρέ­πουν να α­ντι­δρούν ε­κλε­κτι­κά και να συν­δέ­ο­νται με πρω­τε­ΐ­νες. Tï άρ­θρο αυ­τό έ­χει ως σκοπό να πα­ρου­σιά­σει τις βα­σι­κές και σύγ­χρο­νες α­πό­ψεις, κα­θώς και τους μη­χα­νι­σμούς που κα­θο­ρί­ζουν τη στα­θε­ρό­τη­τα μο­ρί­ων mRNA κα­τά την κυτ­τα­ρι­κή α­να­πα­ρα­γω­γή και δια­φο­ρο­ποί­η­ση. Eðé­ðëÝ­ïí, το άρ­θρο αυ­τό πε­ρι­γρά­φει αφ, ε­νός το ρό­λο της στα­θε­ρό­τη­τας ο­ρι­σμέ­νων μο­ρί­ων mRNA σε συ­γκε­κρι­μέ­νες πα­θο­φυ­σιο­λο­γι­κές δια­τα­ρα­χές και τη με­θο­δο­λο­γί­α με την ο­ποί­α προσ­διο­ρί­ζε­ται η στα­θε­ρό­τη­τα τους σε αυ­τές τις κα­τα­στά­σεις και αφ, ε­τέ­ρου τη ρύθ­μι­ση των ε­πι­πέ­δων μο­ρί­ων mRNA α­πό φάρ­μα­κα. TÝ­ëïò, πε­ρι­γρά­φο­νται πει­ρα­μα­τι­κά δε­δο­μέ­να του ερ­γα­στη­ρί­ου μας που α­φο­ρούν συ­σχε­τι­σμούς με­τα­ξύ της με­θυ­λί­ω­σης και της στα­θε­ρό­τη­τας μο­ρί­ων mRNA κα­τά τη δια­φο­ρο­ποί­η­ση νε­ο­πλα­σμα­τι­κών κυτ­τά­ρων με φαρ­μα­κευ­τι­κές ου­σί­ες (ε­πα­γω­γείς).

Most recently, the process of mRNA decay in eukaryotic cells has been widely recog­nized as a major regulatory step in gene expres­sion. This paper is a comprehensive review focus­ing on the potential role of mRNA stability during growth and differentiation of eukaryotic cells, two major processes that are characterized by dramatic changes in the steady-state accumu­lation of mRNA. Furthermore, it provides evidence indicating the different cis- and trans-acting fac­tors which seem to implicate and regulate the process of mRNA decay in eukaryotic cells. Dif­ferent structural elements on mRNA molecules, (5′ cap structure, poly(A)-tail, sequences on 5′ and 3′ UTRs, e.t.c.), in closely co-ordinated inter­action with different isolated and partly or wholly characterized trans-acting factors, (CBPs, PABPs, AU-binding factors, IRE-BPs, e.t.c.), lead into specific and developmentally regulated mRNA de­cay by specific and partly unknown nucleases. The molecular mechanism(s) of degradation of specific mRNAs are presented and especially those responsible for regulation of mRNA stability of tubulins and non-polyadenylated histones as well as mRNAs coded for transferrin receptor via iron availability. Finally, some future perspectives in this rapidly expanding field are presented and discussed in close relation with the development of agents that affect RNA stability and may be used as therapeutics.

Αναφορές – References1.
  1. Belasco, J.G., Higgins, C.F.: Mechanisms of mR­NA decay in bacteria: a perspective. Gene 72: 15-23 (1988)
  2. Atwater, J.A., Widsom, R., Verma, I.M.: Regu­lated mRNA stability. Ann. Rev. Genet. 24: 519-541 (1990)
  3. Hentze, M.W.: Determinants and regulation of cytoplasmic mRNA stability in eukaryotic cells. B.B.A. 1090: 281-292 (1991)
  4. Peltz, S.W., Brewer, G., Bernstein, P., Hart, P.A., Ross, J.: Regulation of mRNA turnover in eukaryotic cells. Critical Reviews.in Eukaryotic. Gene Expres­sion 1: 99-126 (1991)
  5. Belasco, J., Brawerman G. (εds): Control of Mes­senger RNA Stability. Academic Press, San Diego, 1993
  6. Klausner, R.D., Rouault, T.A., Harford, J.B.: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72: 19-28 (1993)
  7. Marzluff, W.F., Hanson, R.J.. Degradation of a nonpolyadenylated messenger: histone mRNA de­cay. In: Control of Messenger RNA Stability (Belasco, J., and Brawerman G., eds), pp. 267-290, Academic Press, ,San Diego, 1993
  8. Theodorakis, N.G., Cleveland, D.W.: Translation­ally coupled degradation of tubulin mRNA. In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 219-238, Academic Press, San Diego 1993
  9. Camper, S.A., Albers, R.J., Coward, J.K., Rott­man, F.M.: Effect of undermethylation on mRNA cytoplasmic appearance and half life. Mol. Cell. Biol. 4: 538-543 (1984)
  10. Sonenberg, N.. Cap-binding proteins of eu­karyotic messenger RNA: function in initiation nand control of translation. Progr. Nucleic Acid Res. Mol. Biol. 35: 173-207 (1988)
  11. Bernstein, P., Ross, J.: Poly(A), poly(A) binding protein and the regulation of mRNA stability. Trends Biochem. Sci. 14: 373-377 (1989)
  12. Kim, C.H., Sarma, R.H.: Spatial configuration of the bizarre 5Ά terminus of mammalian mRNA. J. Am. Chem. Soc. 100: 1571-1590 (1978)
  13. Hickey, E.D., Weber, L.A., Baglioni, C.: Correla­tion between inhibition of protein synthesis and con­formation of 5Ά-phosphorylated 7-methyl-guanosine derivatives. J. Mol. Biol. 109: 173-183 (1977)
  14. Shatkin, A.J.: mRNA cap binding proteins: essen­tial factors for initiating translation. Cell 40: 223-224 (1985)
  15. Tahara, S.M., Darzynkiewicz, E., Stepinski, J., Ekiel, I., Jin, Y., Hahn, C., Strauss, J.H., Sijuwade, T., Haber, D.: Effects of hypermethylated and aber­rant 5Ά-caps on translation of β-globin and Sindbis virus 26S mRNAs. In: Nucleic Acid Methylation (Clawson, C.A., Willis, D.B., Weissbach, A., Jones, P.A., eds.), Vol. 128, pp. 67-82, Alan R. Liss, New York, 1990
  16. Furuichi, Y., LaFiandra, A., Shatkin, A.J.: 5Ά-terminal structure and mRNA stability. Nature 266: 235-239 (1977)
  17. Brawerman, G.: mRNA degradation in eukaryotic cells: an overview..In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 149-159, Academic Press, San Diego, 1993
  18. Stevens, A.: Eukaryotic nucleases and mRNA turnover. In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 449-471, Aca­demic Press, San Diego, 1993
  19. Baker, E.J.: Control of poly(A) length. In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 367-415, Academic Press, San Diego, 1993
  20. Proudfoot, N.: Poly(A) signals. Cell 64: 671-674 (1991)
  21. Jackson, R.J., Stondart, N.D.: Do the poly(A) tail and 3Ά untranslated region control mRNA transla­tion? Cell 62: 15-24 (1990)
  22. Darnell, J.E., Philipson, L., Wall, R., Adesnik, W.M.: Polyadenylic acid sequences: role in conver­sion of nuclear RNA into messenger RNA. Science 174: 507-510 (1971)
  23. Sachs, A., Wahle, E.: Poly(A) tail metabolism and function in eukaryotes. J Biol. Chem. 268: 22955-22958 (1993)
  24. Swartwout, S.G., Kinniburgh, AJ.: c-Myc RNA degradation in growing and differentiating cells: pos­sible alternate pathways. Mol. Cell. Biol. 9: 288-295 (1989)
  25. Muhlrad, D., Parker, R.: Premature translational termination triggers mRNA decapping. Nature 370: 578-581 (1994)
  26. Greenberg, M.E., Belasco, J.G.: Control of the decay of labile protooncogene and cytokine mRNAs. In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 199-218, Academic Press, San Diego, 1993
  27. Shaw, G., Kamen,R.: A conserved AU sequence from the 3Ά untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667 (1986)
  28. Clemens, M.J.: A potential role for RNA tran­scribed from B2repeats in the regulation of mRNA stability. Cell 49: 157-158 (1987)
  29. Schuler, G.D., Cole, M.D.: GM-CSF and onco­gene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor. Cell 55: 1115-1122 (1988)
  30. Wisdson, R., Lee, W.: The protein-coding region of c-myc mRNA contain a sequence that specifiew rapid mRNA turnover and induction by protein syn­thesis inhibitors. Genes Dev. 5: 232-243 (1991)
  31. Kabnick, K.S., and Housman, D.E.: Determinants that contribute to cytoplasmic stability of humn c-fos and β-globin mRNAs are located at several sites in each mRNA. Mol. Cell. Biol. 8: 3244-3250 (1988)
  32. Malter, J.S.: Identification of an AUUUA-specific messenger RNA bindng protein. Science 246: 664-666 (1989)
  33. Brewer, G.: An A + U-rich element RNA-binding factor regulates c-myc mRNA stability in vitro. Mol. Cell. Biol. 11: 2460-2466 (1991)
  34. Vakalopoulou, E., Schaack, J., Shenk, T.: A 32-kilodalton protein binds to AU-rich domains in the 3Ά untranslated regions of rapidly degrated mRNAs. Mol. Cell. Biol. 11: 3355-3364 (1991)
  35. Wickens, M.P., Dahlberg, J.E.: RNA-protein in­teractions. Cell 51: 339-342 (1987)
  36. Burd, C.G., Dreyfuss, G.: Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615-621 (1994)
  37. Sachs, A.B.: Messenger RNA degradation in eukaryotes. Cell 74: 413-421 (1993)
  38. Kozak, M.: Infuences of mRNA secondary structure on initiation by eukaryotic ribosomes. Proc. Natl. Acad. Sci. 83: 2850-2854 (1986)
  39. Klausner, R.D., Harford, J.B.: Cis-trans models for post-transcriptional gene regulation. Science 246: 870-872 (1989)
  40. Klausner, R.D., Rouault, T.A., Harford, J.B.: Regulating the fate of mRNA: the control of cellular iron metabolism. Cell 72: 19-28 (1993)
  41. Stevens, A.: Eukaryotic nucleases and mRNA turnover. In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 449-471, Aca­demic Press, San Diego, 1993
  42. Deutcher, M.P.: Ribonuclease multiplicity, diver­sity, and complexity. J. Biol. Chem. 268: 13011-13014 (1993)
  43. Binder, R., Hwang, S.P.L., Ratnasabapathy, R., Williams, D.L.: Degradation of apolipoprotein II mRNA occurs via endonucleolytic cleavage at 5Ά-AAU-3Ά/5Ά-UAA-3Ά elements in single-stranded loop domains of the 3Ά-noncoding region. J. Biol. Chem. 264: 16910-16918 (1989)
  44. Meinsma, D., Holthuizen, P.E., Vaiden Brande, J.L., Sussenbach, J.S.: Specific endonucleolytic cleavage of IGF-II mRNAs. Biochem. Biophys. Res. Commun. 179: 1509-1516 (1991)
  45. Williams, D.L., Sensel, M., McTigue, M., Binder, R.: Hormonal and developmental regulation of mRNA turnover. In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 161-197, Aca­demic Press, San Diego, 1993
  46. Coutts, M., Brawerman, G.: A 5Ά exoribonucle­ase from cytoplasmic extracts of mouse sarcoma 180 ascites cells. Biochem. Biophys. Acta 1073: 57-62 (1993)
  47. Coutts, M., Krowczynska, A., Brawerman, G.: Protection of mRNA against nucleases in cytoplasmic extracts of mouse sarcoma ascites cells. Biochem. Biophys. Acta 1073: 49-56 (1993)
  48. Bandyopadhyay, R., Coutts, M., Krowczynska, A., Brawerman, G.: Nuclease activity associated with mammalian mRNA in its native state: Possible basis for selectivity in mRNA decay. Mol. Cell. Biol. 10: 2060-2069 (1990)
  49. Brewer, G., Ross, J.: Regulation of c-myc mRNA stability in vitro by a labile destabilizer with an essen­tial nucleic acid component. Mol. Cell. Biol. 9: 1996-2006 (1989)
  50. Sunitha, I., Slobin, L.I.. An in vitro system de­rived from Friend erythroleukemia cells to study messenger RNA stability. Biochem. Biophys. Res. Commun. 144: 560-568 (1987)
  51. Mayer, V.E., Lee, S.I., Steitz, J.A.: Viral small nuclear ribonucleoproteins bind a protein implicated in messenger RNA destabilization. Proc. Natl. Acad. Sci. 89: 1296-1300 (1992)
  52. Gilbert, S.F. (ed.): Developmental Biology. Aca­demic Press, San Diego, 1994
  53. Lodish, H.F., Small, B.: Different life times of re­ticulocyte messenger RNA. Cell 7: 59-65 (1976)
  54. Tsiftsoglou, A.S., Wong, W.: Molecular and cellu­lar mechanisms of leukemic hemopoietic cell differ­entiation: An analysis of the Friend system. Antican­cer Res. 5: 81-100 (1985)
  55. Aviv, H., Volloch, Z., Bastos, R., Levy, S.: Bio­synthesis and stability of globin mRNA in cultured erythroleukemic Friend cells. Cell 8: 495-503 (1976)
  56. Volloch, V., Housman, D.: Relative stability of globin and non-globin mRNA in terminally differentiat­ing Friend cells. In: Organization and Expression of Globin genes (Stamatoyannopoulos, G., Nienhuis, A.W., eds.), pp. 251-257, Alan R. Liss, New York, 1981
  57. Volloch, V., Housman, D.: Regulation of stability of non-globin mRNA in Friend cells. In: Organization and Expression of Globin Genes (Stamatoyannopoulos, G., Nienhuis, A.W., eds.), pp. 259-266, Alan R. Liss, New York, 1981
  58. Krowczynska, A., Yenofsky, R., Brawerman, G.: Regulation of messenger RNA stability in mouse erythroleukemia cells. J. Mol. Biol. 181: 231-239 (1985)
  59. Christou, I-E., Tsiftsoglou, A. S.: Analysis of the developmental regulation of RNA stability in differen­tiating murine erythroleukemia (MEL) cells with the use of a cell free system. Biomed. Pharmacother. 46: 300 (1992)
  60. Volloch, V., Schweitzer, B., Rits, S.: Messenger RNA changes during differentiation of murine erythroleukemia cells. Exper. Cell Res. 173: 38-48 (1987)
  61. Tsiftsoglou, A.S., Christou, I-E., Vizirianakis, I.S.: Developmental changes in methylation of polyA+RNA may regulate its stability posttranscriptionally in murine erythroleukemia (MEL) cells. Proc. Am. As­soc. Cancer Res. 33: 48 (1992)
  62. Vizirianakis, I.S., Tsiftsoglou, A.S.: Induction of murine erythroleukemia cell differentiation is associ­ated with methylation and differential stability of polyA+RNA. Submitted for publication
  63. Christou, I-E., Tsiftsoglou, A.S.: Posttranscrip­tional regulation of polyA+RNA stability in murine erythroleukemia cells by dexamethasone. Mol. Cell. Differ. 2: 329-340 (1994)
  64. Cox, A., Emtage, J.S.: A 6-fold difference in the half-life of immunoglobuin μ heavy chain mRNA in cell lines representing two stages of B cell differen­tiation. Nucleic Acids Res. 17: 10439-10454 (1989)
  65. Genovese, C., Milcarek, C.: Increased half-life of μ immunoglobulin mRNA during mouse B cell devel­opment increases its abundancy. Mol. Immunol. 27: 733-743 (1990)
  66. Genovese, C., Harrold, S., Milcarek, C.: Differ­ential mRNA stabilities affect mRNA levels in mutant mouse myeloma cells. Somatic Cell Mol. Genet. 17: 69-81 (1991)
  67. Cleveland, D.W., Lopata, M.A., Sherline, P., Kirschner, M.W.: Unpolymerized tubulin modulates the level of tubulin mRNAs. Cell 25: 537-546 (1981)
  68. Cleveland, D.W.: Autoregulated instability of tu­bulin mRNAs: A novel eukaryotic regulatory mecha­nism. Trends Biochem. Sci. 13: 339-343 (1988)
  69. Yen, T.J., Machlin, P.S., Cleveland, D.W.: Autoregulated instability of β-tubulin mRNAs by rec­ognition of the nascent amino terminus of β-tubulin. Nature 334: 580-585 (1988)
  70. Stimac, E., Groppi, V.E.,Jr., Coffino, P.: Inhibition of protein synthesis stabilizes histone mRNA. Mol. Cell. Biol. 4: 2082-2087 (1984)
  71. Ross, J., Kobs, G.: H4histone messenger RNA decay in cell-free extracts initiates at or near the 3′ terminus and proceeds 3′ to 5′. J. Mol. Biol. 188: 579-593 (1986)
  72. Peltz, W.W., Ross, J.: Autogenous regulation of histone mRNA decay by histone proteins in a cell-free system. Mol. Cell. Biol. 7: 4345-4356 (1987)
  73. Marzluff, W.F., Pandey, N.B.: Multiple levels of regulation of histone mRNA concentrations. Trends Biocem. Sci. 13: 49-52 (1988)
  74. Morris, T.D., Weber, L.A., Hickey, E., Stein, G.S., Stein, J.L.: Changes in the stability of a human H3 histone mRNA during the HeLa cell cycle. Mol. Cell. Biol. 11: 544-553 (1991)
  75. Harford, J.B.: Iron regulation of transferrin recep­tor mRNA stability. In: Control of Messenger RNA Stability (Belasco, J., Brawerman G., eds), pp. 239-266, Academic Press, San Diego, 1993
  76. Hentze, M.W., Caughman, S.W., Rouault, T.A., Barriocanal, J.C., Dancis, A., Harford, J.B., Klausner, R.D.: Identification of the iron-responsive element for the translational regulation of human ferritin mRNA. Science 238: 1570-1573 (1987)
  77. Haile, D.J., Hentze, M.W., Rouault, T.A., Har­ford, J.B., Klausner, R.D.: Regulation interaction of the iron-responsive element binding protein with iron-responsive RNA elements. Mol. Cell. Biol. 9: 5055-5061 (1989)
  78. Klausner, R.D., Harford, J.B.. Cis-trans models for post-transcriptional gene regulation. Science 246: 870-872 (1989)
  79. Koeller, D.M., Casey, J.L., Hentze, M.W., Ger­hardt, E.M., Chan, L.M., Klausner, R.D., Harford, J.B.: A cytosolic protein binds to structural elements within the iron regulatory region of the transferrin receptor mRNA. Proc. Natl. Acad. Sci. U.S.A. 86: 3574-3578 (1989)
  80. Koeller, D.M., Horowitz, J.A., Casey, J.L., Klausner, R.D., Harford, J.B.: Translation and the stability of mRNAs encoding the transferrin receptor and c-fos. Proc. Natl. Acad. Sci. U.S.A. 88: 7778-7782 (1991)
  81. Müllner, E.W., Kühn, L.C.: A stem-loop in the 3′ untranslated region mediates iron-dependent regula­tion of transferrin receptor mRNA stability in the cy­toplasm. Cell 53: 815-825 (1988)
  82. Müllner, E.W., Neupert, B., Kühn, L.C.: A spe­cific mRNA binding factor regulates the iron-depend­ent stability of cytoplasmic transferrin receptor mR­NA. Cell 58: 373-382 (1989)
  83. Leibold, E.A., Munro, H.N.: Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs. Proc. Natl. Acad. Sci. U.S.A. 85: 2171-2175 (1988)
  84. Gesteland, R.F., Atkins, J.F. (eds.): The RNA World. Cold Spring Harbor Laboratory Press, New York, 1993
  85. Schroeder, R.: Dissecting RNA function. Nature 370: 597-598 (1994)
  86. Purohit, P., Stern, S.: Interactions of a small RNA with antibiotic and RNA ligands of the 30S subunit. Nature 370: 659-662 (1994)
  87. Kozak, M.: Features in the 5′ non-coding se­quences of rabbit α- and β-globin mRNAs that affect translational efficiency. J. Mol. Biol. 235: 95-110 (1994)
  88. Burd, C.G., Dreyfuss, G.: Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615-621 (1994)
  89. Sullenger, B.A., Cech, T.R.: Ribozyme-mediated repair of defective mRNA by targeted trans-splicing. Nature 371: 619-622 (1994)
  90. Pantopoulos, K., Johansson, H.E., Hentze, M.W.: The role of the 5′ untranslated region of eu­karyotic messenger RNAs in translation and its in­vestigation using antisense technologies. In: Progress in Nucleic Acid Research and Molecular Biology (Cohn, W.E., Moldave K., eds), Vol. 48, pp.181-238, Academic Press, San Diego, 1994
  91. Darnell, J., Lodish, H., Baltimore, D. (eds): Mo­lecular Cell Biology,. Scientific American Book, New York), 1986

Online ISSN 1011-6575

Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
Chemical Abstracts

Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor

Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition

Συντακτικη Επιτροπή-Editorial Board

ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
Γλώσσα Πλήρους Κειμένου –
Full Text Language
Ελληνικά – Greek
Παραγγελία – Αγορά –
Order – Buy
Ηλεκτρονική Μορφή: pdf (70 €) –
Digital Type: pdf (70 €)
pharmakonpress[at]pharmakonpress[.]gr
Έντυπη Μορφή (70 € + έξοδα αποστολής)
Printed Type (70 € + shipping)
pharmakonpress[at]pharmakonpress[.]gr

 

Προσθέστε στους σελιδοδείκτες το μόνιμο σύνδεσμο.

Τα σχόλια είναι απενεργοποιημένα.